Andion, M., Molina, B., Gonzalez-Vicent, M., et al. (2011) High-Dose Busulfan and Cyclophosphamide as a Conditioning Regimen for Autologous Peripheral Blood Stem Cell Transplantation in Childhood Non-Hodgkin Lymphoma Patients: A Long-Term Follow-Up Study. Journal of Pediatric Hematology/Oncology, 33, e89-e91.
https://doi.org/10.1097/MPH.0b013e3181fd6c79

has been cited by the following article:

• TITLE: Severe Hepatic Sinusoidal Obstruction Syndrome during the Induction Chemotherapy of Burkitt’s Lymphoma

  AUTHORS: Line Couitchere, Yao Nicaise Atiméré, Daouda Koné, Delphine Lagou

  KEYWORDS: Lymphoma, Treatment, Veno-Occlusive Disease, Multi Organ Failure

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.8 No.1, March 9, 2018

  ABSTRACT: The Hepatic sinusoidal obstruction syndrome (HSOS), also known as veno-occlusive disease (VOD), is a well-known complication of haematopoietic stem cell transplantation, of the treatment of Wilms tumor and rhabdomyosarcoma and maintenance therapy of acute lymphoblastic leukemias. Its occurrence is rare in other cancers of the child. We report the observation of a 7-year-old girl with Burkitt’s lymphoma who developed a severe HSOS during her second induction treatment with dexamethasone, cisplatin, cytosine arabinoside. The evolution was fatal. This observation shows that the diagnosis of HSOS should not be excluded in the absence of the risk factors usually described.